Consensus Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Market Closed - NYSE Other stock markets 16:00:03 2026-08-06 EDT			Pre-market 08:45:56
17.02 ^USD	+1.79%		17.66	+3.76%

08-05	Takeda Wins FDA Approval for First-in-Class Narcolepsy Treatment ORZEYFUL	MT
08-05	Takeda Receives U.S. Fda Approval for Orzeyful (Oveporexton) to Treat Narcolepsy Type 1	CI

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

34cd60237da68010ad76e.dOQ04ramSKhaUQG3I6Zwq0fbyZS5f6xdcKKnfd5DYBM.QZVhvdnfKsIAHEuHZ88Y8TGzh9LQLug_XcvpGuYZB3Qkk2Gs_Mt_3TsmUA~998ab457dfe38d0f900bee9ec5eeb656

Analysts' recommendations: Takeda Pharmaceutical Company Limited

07-28	SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target	MT
07-24	China Merchants Starts Takeda Pharmaceutical at Buy with 6,600 Yen Price Target	MT
03-30	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
01-30	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
25-09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
25-08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
25-05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
25-05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
17-09-08	BAYER : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
TAKEDA PHARMACEUTICAL COMPANY LIMITED	-	-	-	-
ELI LILLY AND COMPANY				+8.84%
JOHNSON & JOHNSON				+6.04%
ABBVIE INC.				+12.11%
ROCHE HOLDING AG				-0.21%
NOVARTIS AG				-0%
ASTRAZENECA PLC				+32.61%
AMGEN INC.				-7.45%
NOVO NORDISK A/S				+7.31%
GILEAD SCIENCES, INC.				+20.29%
Average				+8.84%
Weighted average by Cap.				+8.20%